在急性心肌梗塞后,例行冠状动脉血管学的成本效益
K M Kuntz1, J Tsevat, L Goldman
1Section for Clinical Epidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. keaney@hsph.harvard.edu
Circulation
|September 1, 1996
概括
急性心肌梗塞 (AMI) 后的冠状动脉造影对于特定的患者亚组来说是具有成本效益的,特别是那些患有严重心痛或先前心脏病发作的人. 这种策略与单独的初始医疗治疗相比,提供了有利的结果.
科学领域:
- 心脏病学 心脏病学
- 卫生经济学 卫生经济学
- 临床决策 - 临床决策
背景情况:
- 冠状动脉扫描是急性心肌梗塞 (AMI) 后的标准,但对某些患者群体的必要性尚不清楚.
- 确定AMI管理的成本有效策略对于资源分配至关重要.
研究的目的:
- 评估常规冠状动脉血管学与初始医疗治疗在各种急性心肌梗塞 (AMI) 患者小组中的成本效益.
- 根据AMI后冠状动脉血管学最佳时间和使用情况,为临床决策提供信息.
主要方法:
- 通过从临床试验和文献中汇集的数据开发了一个决策分析模型.
- 对两个管理策略进行了质量调整后预期寿命和终身成本估计.
- 数据来源包括医疗保险A部分的费用和患者调查,以调整生活质量.
主要成果:
- 血管造影的增量成本效益比率从每年获得的质量调整后的生活年数为17.000美元至100万美元以上.
- 患有严重心脏病发作后心痛或积极的运动耐受性测试 (ETT) 的子组显示比率低于50,000美元/QALY.
- 患有先前AMI的患者也表现出低于5万美元/QALY的成本效益,即使有负的ETT结果.
结论:
- 常规冠状动脉血管造影对于精选的急性心肌梗塞 (AMI) 患者小组来说是具有成本效益的.
- 这些发现支持在患有严重胸痛,阳性ETT或先前AMI的患者中使用血管造影.
- 这一策略在这些特定人群中与其他冠状动脉心脏病治疗相比较有利.
相关概念视频
Imaging Studies for Cardiovascular System I:Echocardiography
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


